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The Haploinsufficient Tumor Suppressor p18
Upregulates p53 via Interactions with ATM/ATR
this complex play unexpected roles in diverse biological
processes (Han et al., 2003; Ko et al., 2002). Among the
three cofactors in the complex, p18 is the smallest one
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To obtain insight into the physiological significanceSummary
and working mechanism of p18, we tried to generate
p18-depleted mice. However, the loss of p18 resulted inp18 was first identified as a factor associated with a
macromolecular tRNA synthetase complex. Here we early embryonic lethality. Although this outcomedefined
p18 as an essential factor for the embryogenesis anddescribe the mouse p18 loss-of-function phenotype
and a role for p18 in the DNA damage response. Inacti- viability of the organism, we could not obtain clues to
theworkingmechanismof p18 in vivo. Instead,we foundvation of both p18 alleles caused embryonic lethality,
while heterozygous mice showed high susceptibility that the p18 heterozygous mice expressed a lower level
of p18 as compared to the wild-type littermates, and, asto spontaneous tumors. p18 was induced and translo-
cated to the nucleus in response to DNA damage. they aged, the heterozygous mice frequently developed
various tumors, implying the functional association ofExpression of p18 resulted in elevated p53 levels,while
p18depletionblockedp53 induction. p18directly inter- p18 with cell cycle control and tumorigenesis. The fol-
lowing molecular and cellular analyses unveiled the ac-acted with ATM/ATR in response to DNA damage. The
activity of ATM was dependent on the level of p18, tivity of p18 as a positivemodulator of the ATM response
to DNA damage. The functional importance of p18 assuggesting the requirement of p18 for the activation
of ATM. Low p18 expression was frequently observed tumor suppressor was further supported by examining
its expression in human cancer cell lines and tissues.in different human cancer cell lines and tissues. These
results suggest that p18 is a haploinsufficient tumor
suppressor and a key factor for ATM/ATR-mediated Results
p53 activation.
Spontaneous Tumorigenesis in p18
Introduction Heterozygous Mice
The p18 heterozygous mice were generated from em-
Aminoacyl-tRNA synthetases ligate specific amino bryonic stem cells containing a gene trap insertion at
acids to their cognate tRNAs in protein synthesis. How- the p18 gene, following the standard protocol of Lexicon
ever, they are functionally versatile proteins involved in Genetics (Zambrowicz et al., 1998). The genotypes of
various biological processes (Ko et al., 2002). One of the offspring generated from the intercross between the
the most intriguing characteristics of mammalian tRNA heterozygous mice were determined by genomic PCR
synthetases is that several different aminoacyl-tRNA and Southern blot analyses. For the PCR analysis, two
synthetases form a unique macromolecular protein primers specific to thep18 geneweredesigned togener-
complex with nonenzyme factors, designated as p43, ate a 1.5 kb DNA, and one additional primer for the
p38, and p18. Interestingly, many of the components of inserted gene trap vector would generate about 0.8 kb
DNA with the forward p18 primer. Thus, the wild-type
and homozygous mice would produce 1.5 and 0.8 kb*Correspondence: sungkim@snu.ac.kr
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Figure 1. Genetic Characterization and Tu-
mor Occurrence of p18-Deficient Mice
(A) The insertion of the gene trap vector into
the p18 gene was determined by a genomic
PCR analysis. Genomic DNA was isolated
from the mouse tail, and the pair of primers,
p18F-1 andp18R-1,wasdesigned to produce
a 1.5 kb PCRproduct from thewild-typeDNA.
An additional band of 0.8 kb is generated with
the primer p18F-1 and LTR binding to the
inserted gene trap vector (about 5.7 kb). The
data for the homozygousmouse are not avail-
able due to embryonic lethality.
(B) Southern blot analysis with SacI-digested
genomic DNA, using a DNA probe generated
by PCR with the pair of primers p18F-2 and
p18R-2. While the wild-type shows one band
near 12 kb, the heterozygote generates one
additional band of about 3 kb.
(C) Schematic representation of the gene trap
insertion into the p18 gene.
(D) Expression of p18 in different p18/ and
p18/ tissues, as determined by Western
blotting with an anti-p18 antibody. Tubulin
was used for a loading control.
(E) The mice were classified into three groups
according to their ages and the number of
mice examined, and the tumor incidence in
each group is represented as a bar graph.
White and gray bars indicate the total num-
bers of autopsied wild-type and heterozy-
gous mice, respectively, and the black sec-
tion in each bar represents the number of
mice with tumors.
bands, respectively. Interestingly, all of the examined antibody. In most of the tested organs, the p18 level
was significantly lower in the heterozygotes, althoughoffspring were determined to be the wild-type or hetero-
zygote generating both the 1.5 and 0.8 kb DNA frag- the degree of reduction varied depending on the tissue
(Figure 1D). The p18/ mice showed a similar and evenments (Figure 1A). In addition, a Southern blot analysis
was performed using the genomic DNAs digested with slightly higher growth rate as compared to both genders
of their wild-type littermates (Supplemental Figure S1).SacI, with a probe covering the exon II region of p18.
While the wild-type DNA showed the hybridization band Although the growth and overall morphology of the
p18/ mice looked normal, they spontaneously devel-at about 12 kb, the heterozygous mice generated an
additional band at about 3 kb (Figure 1B). In both tests, oped different types of tumors, and the incidence signifi-
cantly increased when they were older than 15 monthswe could not find offspring with the p18 homozygous
genotype (see Supplemental Table S1 at http://www. (Figure 1E).
cell.com/cgi/content/120/2/209/DC1/). The sequencing
analysis determined the site of the gene trap vector Histological Characterization of Tumors
The tumors developed in the p18/ mice were charac-insertion between exons I and II (Figure 1C). To deter-
mine whether the loss of p18 leads to embryonic lethal- terized by H&E staining and immunohistochemistry
when necessary. Adenocarcinomas in breast tissueity, we checked the genotypes of embryos on different
days after fertilization. Among the total of 83 embryos were found in 15- and 23-month-old heterozygous mice
(see Supplemental Figure S2A on the Cell web site andisolated from 7.5 to 9.5 days, we detected only one
embryo on E8.5 containing the homozygous genotype data not shown), a sarcoma of unknown origin devel-
oped in a 22-month-old mouse (Supplemental Figure(Supplemental Table S1), indicating that p18/ mice
would be early embryonic lethal. The heterozygousmice S2B), and an adenocarcinoma in the seminal vesicle
was detected in a 19-month-old mouse (Supplementalwere born at a ratio similar to the wild-type littermates
(Supplemental Table S1), indicating that about 50% of Figure S2C). All of these cancers showed typical malig-
nant phenotypes such as anaplasia and invasiveness.the heterozygous mice die during the prenatal stage.
We then isolated various organs from the p18/ mice Remarkably, the seminal vesicles of the heterozygous
mice showed three cystic change cases, one hyperpla-and compared their p18 levels with those of their wild-
type littermates by Western blotting with an anti-p18 sia (data not shown), and one adenoma (Supplemental
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Figure S2D). Well-differentiated adenocarcinomas origi- ued to reside in the nuclei during S phase (Supplemental
Figure S3D). All of these results indicate that p18 is notnating from the bronchiole epithelium were observed in
only induced but also translocated into the nucleus to17- and 22-month-old mice (Supplemental Figures S2E
exert its activity during DNA synthesis.and S2F). Hepatocarcinomawas detected in a 22-month
We then investigated the role of p18 in the cellularold mouse (Supplemental Figure S2G). Interestingly, 14
response to stress-induced apoptosis and growth ar-of the 18 tumor-bearing mice developed lymphoma
rest. The p18/ andp18/ splenocyteswere compared(Supplemental Table S1), originating from the spleen or
in their response to proapoptotic stress induced bylymph nodes (Supplemental Figures S2H, S2I, and S2K).
adriamycin, which causes DNA damage. While the num-Some of the lymphomas metastasized to other organs,
ber of apoptotic cells significantly increased when thesuch as the liver, kidney, lung, and salivary glands (Sup-
wild-type cells were treated with adriamycin, the p18/plemental Figures S2J and S2K and data not shown).
cells showed resistance to adriamycin-induced apopto-To confirm this, we performed an immunohistochemical
sis, as determined by FACS analysis using annexin Vanalysis with the anti-B220 monoclonal antibody and
and PI staining (Figure 2F and Supplemental Figuresdifferentially diagnosed the lymphoma from reactive hy-
S4A and S4B). When the p18/ and p18/ cells wereperplasia, because the white pulp architectures were
treated with adriamycin, the growth of the p18/ cellsdisrupted by B220 lymphoma cells (Supplemental Fig-
was only slightly affected by the adriamycin treatment,ures S2J and S2K). We also found five cases of multiple
while the wild-type cell growth was arrested (Supple-cancers (Supplemental Table S1). The fact that these
mental Figure S4C). We then checked whether the leveltumors spontaneously formed in the heterozygous mice
of p18 was affected by adriamycin treatment. p18 wasled us to suspect that p18 might be a strong tumor
strongly induced in response to adriamycin, as deter-suppressor involved in a general tumorigenic pathway,
mined by RT-PCR and Western blot analyses (Figurealthough it showedmore significant linkage to the occur-
2G). The induction of p18 was also observed with otherrence of lymphoma.
DNA damaging agents, such as UV, actinomycin D (Act.
D), and cisplatin (CDPP) (Supplemental Figure S4D).p18 Regulates the Cell Cycle and Apoptosis
Time course analyses showed that the induction of p18Since a rapid cell cycle and resistance to apoptosis are
was achieved within 5–10 min after the exposure to UVtypical indications for tumorigenesis (Evan and Vous-
or adriamycin (Figure 2H). The nuclear localization ofden, 2001), we addressed whether p18 could play a role
p18, as a consequence of DNA damage, was also ob-in cell cycle control. We first compared the cell growth
served using U2OS cells (Supplemental Figure S4E). Inof splenocytes and thymocytes isolated from the wild-
this cell line, the nuclear foci formed by p18 cells weretype and p18/ littermates by cell counting. The cells
clearly observed. All of these results suggest that p18isolated from the p18/mice grew faster than did those
may be involved in a response to DNA damage that mayof the wild-type (Figure 2A). The enhanced proliferation
occur during the cell cycle or by genotoxic stresses.was also observed in the p18/ MEF cells by tritium-
labeled thymidine incorporation (Supplemental Figure
p18 Upregulates p53S3A). Increased numbers of proliferative cells were de-
Since the tumor suppressor protein p53 plays a major
tected in various p18/ tissues by in situ immunofluo-
role in the regulation of DNA damage-induced cell cycle
rescence staining with the proliferation marker Ki-67
arrest and apoptosis (Levine, 1997; Vousden, 2000), we
(Supplemental Figure S3B). When we measured the cell explored the possibility of a functional connection be-
cycle progression by flow cytometry, the p18/ spleno- tween p18 and p53. Interestingly, the level of p53 was
cytes showed a faster cell cycle than the wild-type cells lower in the p18/MEFs than that in the wild-type cells,
(Figure 2B). while the ectopic expression of p18 elevated the p53
To obtain insight into the function of p18 during the expression (Figure 3A). To determine whether an in-
cell cycle, we synchronized the cell cycle by serum star- crease in p18 would enhance the p53-dependent tran-
vation and refeeding andmeasured the expression level scription, we measured the p18-dependent transcrip-
of p18 during different cell cycle phases by Western tion of p21, which is a known target gene of p53. The
blotting. p18 was significantly induced during the DNA synthesis of the p21 transcript was enhanced by the
synthesis phase (Figure 2C). Consistently with theWest- ectopic expression of p18, as determined by RT-PCR
ern blotting, a FACS analysis also showed an increase (Figure 3B). The effect of p18 on the p21 transcription
in the p18 level during S phase (Supplemental Figure was also checked by a luciferase assay, using a con-
S3C). To understand the functional reason for the p18 struct bearing p21 promoter fused to the luciferase
induction during S phase, we investigated the cellular gene. The luciferase activity was elevated by the trans-
localization of p18 under growth arrest and proliferating fection of p18 in a dose-dependent manner (Figure 3C),
conditions. When the cell growth was suppressed by further supporting the significance of p18 for the control
serum starvation, p18 was mainly located in the cyto- of p53 activity. Since the reduction of the p18 level in-
plasm. However, it was detected in the nucleus when creased the cell proliferation (Figures 2A and 2B and
the cells resumed growth (Figure 2D). The localization Supplemental Figures S3A and S3B), we tested whether
of p18was further examined in different cell cycle stages the forced expression of p18 would suppress cell prolif-
using tubulin as reference. The nuclear translocation of eration. As expected, transfection of p18 reduced the
p18 was clearly observed in the S phase cells (Figure proliferation of HCT116 cells, and its antiproliferative
2E). When the cell cycle was synchronized by double activity was abolished in the absence of functional p53
thymidine block, p18 was also nuclear translocated or p21 (Figure 3D), implying that p18 suppresses cell
proliferation via p53.within 1 hr after the cell cycle restarted, and p18 contin-
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Figure 2. Induction of p18 by DNA Replication and Damage
(A) The cell proliferation rate was measured by cell counting of splenocytes and thymocytes isolated from 4-week-old p18/ and p18/ lit-
termates.
(B) Cell cycle progression was determined by flow cytometry. The p18/ and p18/ splenocytes were stained with PI after cultivation for 1
day and fixed with 1% PFA. The green line and blue-filled graph indicate p18/ and p18/ cells, respectively. For each sample, 20,000 cells
were analyzed.
(C) The expression profile of p18 at different cell phases was determined by Western blotting with an anti-p18 antibody. HCT116 cells were
starved in serum-free medium for 24 hr, and then complete medium was added to start the cell cycle. The cells were harvested at the indicated
times and analyzed for expression of p18. Cyclin E and tubulin were used as markers for the cell cycle and the loading amount, respectively.
SF indicates serum-free condition.
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To determinewhether p18 is critical for p53 activation, p18 Directly Interacts with ATM/ATR in Response
to DNA Damagewe conducted antisense (As) and small interfering (si)
RNA techniques to block the expression of p18 and The results above suggest that p18 somehow activates
ATM in response toDNAdamage. To elucidate thework-monitored the effect of p18 suppression on the induction
of p53. As- or si-p18 reduced the expression of p18, ing mechanism of p18, we performed coimmunopreci-
pitations of ATM with p18. The cells were incubatedas determined by RT-PCR (Figure 3E). Since As-p18
appeared to be more effective than si-p18 in blocking under serum-free conditions, and growth was resumed
by feeding complete medium. The interaction of ATMthe expression of p18, we used As-p18 to suppress p18
with p18 was weak under the growth arrest conditionsand evaluated the significance of p18 in p53 induction.
(serum-free) but became stronger when the cells wereA treatment with UV increased the p53 level, whereas
treated with adriamycin or fed with the complete me-the suppression of p18 by As-p18 blocked the induction
dium (Supplemental Figure S5A), suggesting that theof p53 (Figure 3F), demonstrating the requirement of
interaction between ATM and p18 would be induced byp18 for the increase in p53. The transcription of the
DNA damage that may occur during genotoxic stressimmediate early p53 target gene, PUMA (Nakano and
or cell growth. The interaction between these two pro-Vousden, 2001; Yu et al., 2001), was also increased by
teins in response to UV and adriamycin increased withinUV exposure, but the induction was blocked when p18
10 min after the introduction of stresses (Figure 5A).was suppressed by As-p18 (Figure 3G). All of these re-
However, the dissociation of p18 appeared to be muchsults support the idea that p18 is critical for the DNA
slower in the adriamycin-treated cells, possibly becausedamage-dependent induction of p53.
the adriamycin was present in the medium throughout
the cultivation, while the UV stress would affect the cells
Critical Role of ATM in p18-Dependent only temporarily. Since ATM is an upstream regulator
Regulation of p53 of p53, the interaction between p18 and ATM should
To address how p18 regulates p53, we tested whether be achieved in a p53-independent manner. To test this
p18 directly interacts with p53 by coimmunoprecipita- possibility, we repeated the coimmunoprecipitation ex-
tion but could not obtain supportive evidence (data not periments in human prostate cancer DU145 cells, which
shown). We then checked the involvement of ATM/ATR, lack functional p53 (Isaacs et al., 1991). p18 bound to
because they are the immediate upstream activators of ATM in DU145 cells in response to UV and adriamycin
p53 in response to DNA damage (Canman et al., 1998). treatments (Supplemental Figure S5B), confirming that
To explore the functional involvement of these kinases the interaction of p18 and ATM can take place indepen-
in the role of p18, we compared the antiproliferative dently of p53. We thenmonitored the time course for the
activity of p18 in the isogenic ATM-deficient fibroblasts nuclear localization of p18 induced by these stresses. In
(AT22IJE-T), harboring the empty vector (S7) and the both cases, p18was translocated into the nucleuswithin
functional ATM (YZ-5). While p18 suppressed the prolif- 10 min after the onset of the stress (Figure 5B), consis-
eration of ATM-positive YZ-5 cells, its suppressive effect tent with its interaction with ATM.
was not observed in ATM-negative S7 cells (Figure 4A). Next, we tested whether p18 can also interact with
Apoptosis was also induced by the forced expression ATR. The Flag-tagged ATR was expressed in 293 cells
of p18, but its proapoptotic activity was also blocked and immunoprecipitated with anti-Flag antibody, and
in the absence of functional ATM (Figure 4B). the coprecipitation of p18 was determined by Western
We also compared the effect of p18 on the induction blot analysis. The interaction of p18 with ATR was also
and activity of p53, using the two isogenic ATM-positive observed, and it was enhanced by UV irradiation (Figure
and -negative cell lines used above. Western blotting 5C). The direct interaction of ATM/ATR with p18, and
of p53 showed that it is increased by the transfection of their binding domains, were determined by in vitro pull-
p18 in YZ-5 (ATM-positive) but not in S7 (ATM-negative) down assay. The ATM/ATR homology FAT and PI3K
cells (Figure 4C).When the activity of p53wasmonitored catalytic domains were synthesized in vitro in the pres-
by the expression of its target gene, PUMA, the stimula- ence of [35S] methionine, and each of them was incu-
tory effect of p18 was shown only in YZ-5 cells (Figure bated with GST-p18 or GST-p38, and the bound do-
4D). The p18-dependent induction of p53 was blocked mains were determined by autoradiography. Among the
by the expression of the kinase-dead domain of ATM three tested domains, only the FAT domains of ATM
(KD-ATM), which inhibits the activity of ATM (Canman and ATR were copurified with GST-p18, but none of
et al., 1998), but not by the wild-type ATM (Figure 4E). these domains bound toGST-p38 (Figure 5D), indicating
All of these results support the requirement of ATM for the direct interaction of p18 with the FAT domains of
ATM and ATR despite their limited homology.the p18-dependent induction of p53.
(D) The cellular localization of p18 was observed by immunofluorescence microscopy in DU145 cells cultivated in serum-free medium (SF,
left column). The cells were fed with complete medium (CM) to resume proliferation and stained as above. The nuclei were stained with PI
(red). The cellular localization of p18 (upper) is enlarged to demonstrate that nuclear p18 is present as foci (lower).
(E) The localization of p18 was monitored in DU145 cells at different stages. p18 and tubulin are shown in green and red colors, respectively.
(F) Apoptotic response of splenocytes to adriamycin treatment. The responses of the p18/ and p18/ cells to apoptotic stress were
compared by monitoring annexin V or PI staining using flow cytometry (see Supplemental Figures S4A and S4B).
(G) Induction of p18 in response to the treatment with adriamycin. The expression of p18 was monitored by RT-PCR (upper) and Western
blotting (lower) in HCT116.
(H) Time course for the induction of p18 by UV irradiation and adriamycin treatment, as determined by Western blotting.
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Figure 3. p18 Is Required for p53 Induction
(A) The expression levels of p18 and p53 were compared between p18/ and p18/ MEFs (left). The effect of ectopic overexpression of p18
on the level of p53 was performed in HCT116 cells (right). EV stands for empty vector.
(B) The effect of p18 on the p53-dependent transcription of p21 was determined by RT-PCR. HCT116 cells were transfected with p18 (1 g/
ml) and cultivated for 24 hr. The cells were lysed to isolate the RNA, as described in Experimental Procedures, and the synthesis of the p21
transcript was determined by RT-PCR.
(C) The activity of p18 in the p53-dependent transcription of p21 was also determined by a luciferase assay using the construct with the
luciferase gene under p21 promoter control. HCT116 cells were transfected with the indicated concentrations of the p18 plasmid and
cultivated for 24 hr. The luciferase activity was measured with a luminometer. The -galactosidase expression vector was also transfected
for background calibration.
(D) We transfected the p18 expression vector or EV (2 g/ml) into HCT116 (wt) and those cells lacking p53 or p21 and checked the effect of
p18 on cell proliferation by measuring [3H] thymidine incorporation.
(E) Comparison of the antisense (As) and siRNA on the expression of p18 by RT-PCR. HCT116 cells were transfected with si- or As-p18 (2
g/ml each) and cultivated for 24 hr.
(F) The significance of p18 on the induction of p53 by UV irradiation (50 J/m2) was assayed using antisense p18 (As). HCT116 cells, transfected
with EV or AS-p18 (2 g/ml), were subjected to Western blotting for p53 and p18 1 hr after UV exposure. Actin was used for a loading control.
(G) The effect of p18 on the expression of PUMA, an immediate early response gene of p53, was assayed by RT-PCR under the same
conditions as above.
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Figure 4. ATM Is Required for p18-Dependent Induction of p53
(A) The requirement of ATM for the antiproliferative activity of p18 was tested in the ATM-deficient human fibroblast line AT22IJE-T carrying
the empty vector (S7) or the plasmid encoding functional ATM (YZ-5) (Li et al., 2000). p18 was transfected into these cells, and its effect on
cell proliferation was determined by thymidine incorporation.
(B) The significance of ATM in the proapoptotic activity of p18 was also assessed using the two cell lines above. Apoptosis was measured
by the portion (%) of sub-G1 cells after PI staining (number above the bar).
(C) The effect of the ectopic expression of p18 on the induction of p53 was determined by Western blotting in the ATM-positive YZ-5 and
ATM-negative S7 cells.
(D) Under the same experimental conditions, we assessed the expression of the p53 target gene PUMA by RT-PCR in YZ-5 and S7 cells.
(E) The effect of kinase-dead ATM (KD-ATM) was examined on the p18-dependent induction of p53. HCT116 cells were transfected with p18
in combination with wild-type (wt) or KD-ATM, and the expression levels of p18 and p53 were determined by Western blotting.
p18 Activates ATM Among the tested cell lines, the expression level of p18
was reduced in HCT116, A549, and H460 cells, althoughTo see whether the activity of ATM is enhanced by its
association with p18, we monitored the activity of ATM the degree of suppression varied depending on the cell
type (Figure 7A). When we compared the expressionin a few different ways. We first examined the effect of
p18 on the phosphorylation of ATM itself, which indi- level of p18 by Western blotting among different lung
cancer cell lines, wealsoobserved the results consistentcates its activation. The ectopic expression of p18 in-
creased the phosphorylation of ATM (Figure 6A). While with those obtained by RT-PCR (Figure 7B). These find-
ings suggest that the p18 expression level is reduced inthe phosphorylation of ATM was enhanced by adriamy-
cin treatment, it was inhibited by the expression of anti- some cancer cell lines. Interestingly, the p18 expression
level appears to be linked to the functionality of p53.sense p18 (As-p18) in HCT116 cells (Figure 6B). The
adriamycin-dependent activation of ATM was also Namely, the p18 level is low in the cells containing active
p53, while it is normal in the cells lacking functional p53blocked in the p18/ thymocytes (Figure 6C). We also
investigated the adriamycin-dependent nuclear foci for- (Figure 7A). Moreover, Raji cells, which display partial
p53 activity (Bhatia et al., 1993), appeared to expressmation of ATM in the p18/ and p18/ cells. The nu-
clear foci of ATM were observed in the normal cells p18 at an intermediate level between p53-positive and
-negative cells. This observation implies that oneaberra-when they were treated with adriamycin but not in the
p18/ cells (Figure 6D). All of the above results consis- tion, in either p18 or p53, may be sufficient to transform
the cells, further supporting the possibility that p18 andtently suggest that p18 is required for the activation
of ATM. p53 work in the same signal pathway. To obtain insight
into the possible cause for the low level of p18 in some
cancer cell lines, we compared the DNA content for theLow Expression of p18 in Human
p18 gene by PCR, using isolated genomic DNA as theCancer Cells and Tissues
template. Among the three tested cell lines with low p18To determine whether a functional association of p18
expression, H460 and A549 cells appeared to containexists with human cancers, we first checked the p18
levels in different human cancer cell lines by RT-PCR. lower amounts of DNA encoding p18 than other cells
Cell
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Figure 5. p18 Directly Interacts with ATM
(A) The stress-induced interaction of p18 with ATM was determined by coimmunoprecipitation. HCT116 cells were either UV irradiated or
treated with adriamycin (0.4 g/ml). The cells were harvested at the indicated times and subjected to immunoprecipitation with an anti-ATM
antibody, and coimmunoprecipitation of p18 was determined with its specific antibody.
(B) Cellular localization of p18 was determined by immunofluorescence staining in DU145 cells irradiated by UV or treated with adriamycin.
p18 and nuclei were stained with the FITC-conjugated secondary antibody and PI, respectively. Insets showed the nuclear as well as the
cytoplasmic presence of p18 at 10 min after genotoxic stresses at higher magnification.
(C) The interaction of p18 with ATR was determined by coimmunoprecipitation. 293 cells were transfected with the Flag-tagged ATR, UV
irradiated, and immunoprecipitated with the anti-Flag antibody, and coprecipitation of p18 was determined by Western blotting with an anti-
p18 antibody.
(D) The domain of ATM/ATR responsible for the interaction (Abraham, 2001) with p18 was determined by in vitro pull-down assay. p18 and
p38 (used as a control) were expressed as the GST fusion proteins. The ATM/ATR homology domain (496 aa from 1489 to 1984 in ATM and
459 aa from 1181 to 1639 in ATR), FAT domain (641 aa from 1942 to 2582 in ATM and 698 aa from 1625 to 2322 in ATR), and PI3K catalytic
domain (473 aa from 2561 to 3033 in ATM and 403 aa from 2213 to 2615 in ATR) were radioactively synthesized by in vitro translation and
reacted with each of GST-18 and -p38 immobilized to glutathione-Sepharose beads. The domains bound to each of the GST fusion proteins
were separated by SDS gel electrophoresis and determined by autoradiography. “In” stands for the input of the in vitro-translated domains
of ATM and ATR.
(Figure 7C), implying that these cell lines may have lost taining the p18 gene (6p24), based on cytogenetic analy-
sis of ATCC.one p18 allele. In fact, the A549 cell line is already known
to have lost one allele of the chromosome region con- We then examined the expression of p18 in tissues
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Figure 6. p18-Dependent Activation of ATM
(A) The effect of the ectopic expression of p18 on the phosphorylation of ATM was determined in HCT116 by Western blotting with the
antiphosphoserine antibody of ATM (Bakkenist and Kastan, 2003).
(B) The adriamycin-dependent phosphorylation of ATM was compared in the absence and presence of antisense p18 (As-p18) in HCT116.
(C) The adriamycin-dependent activation of ATM was determined in the p18/ and p18/ thymocytes by Western blotting.
(D) The effect of p18 on the adriamycin-dependent nuclear foci formation of ATM was compared in the p18/ and p18/ splenocytes (600).
isolated fromhuman cancer patients. Among nine differ- thetase complex (Kim et al., 2002). Interestingly, p38
plays an important role in the downregulation of c-mycent cases of leukemia (five acute promyelocytic leuke-
mia cases and four chronic myelocytic leukemia cases), and lung cell differentiation (Kim et al., 2003). Thus, both
p18 and p38 are involved in cell cycle control and possi-low p18 levels were observed in three cases (Figure 7D,
patients 1, 5, and 6). In these three cases, the expression bly in tumorigenesis, although their working mecha-
nisms are different. Perhaps they were evolved to co-of the p53 target gene p21 was also strongly sup-
pressed, corroborating the functional significance of ordinate the basal protein synthesis process with
important signal pathways for the cell cycle. It would bep18 in the regulation of p53. Solid tumors were also
found in p18/mice, although the frequency was much interesting to see whether a related activity also exists
in p43, although it is already known to have complexlower. Therefore, we also compared the p18 level in
cancerous tissue with that in normal tissue isolated from cytokine activity (Ko et al., 2001; Park et al., 2002).
The loss of p18 resulted in early embryonic lethality,human liver cancer patients. From the analyses of 25
different patient samples, we observed the cancer-spe- indicating its functional importance in vivo (Supplemen-
tal Table S1). Similarly, the genetic eradication of pro-cific reduction of p18 in 12 cases (Figure 7E and data
not shown). All of these results suggest that low p18 teins such as Rad51, Chk1/2, and ATR, which are in-
volved in the DNA damage response and repair system,expression may be frequently associated with various
human cancers. caused early embryonic lethality (de Klein et al., 2000;
Lim and Hasty, 1996; Takai et al., 2000). In addition, the
p18/ mice frequently developed lymphoma (Supple-Discussion
mental Figure S2 and Supplemental Table S1), which is
consistent with previous reports that the loss of a DNAThree different lines of evidence obtained in this work
unveiled the activity of p18 as an upstream regulator of repair function can evoke lymphoma (Bassing et al.,
2003; Celeste et al., 2003). Moreover, p18 is induced andp53 via ATM/ATR and as a tumor suppressor. First, the
p18 heterozygous mice with the reduced level of p18 translocated to the nucleus during the DNA synthesis
phase and in response to DNA damage (Figures 2D, 2E,show a high incidence of spontaneous tumorigenesis.
Second, p18 directly binds and activates ATM to upreg- and 5B, and Supplemental Figures S3D and S4E) and
shows antiproliferative activity like other DNA repair pro-ulate p53 in response to DNA damage. Third, low p18
expression is observed in human cancer cell lines and teins (Figures 3D, 4A, and 4B) (Falck et al., 2001; Lim et
al., 2000). All of these phenotypic characteristics andtissues. p18 is known to bind to the multi-tRNA synthe-
tase complex with two other auxiliary factors, p43 and molecular behaviors strongly suggest the role of p18
in the process of DNA repair during DNA replicationp38. Among them, p38 was previously shown to be a
critical scaffold for the assembly of the multi-tRNA syn- and stress.
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Figure 7. Expression of p18 in Human Cancer Cell Lines and Patient Tissues
(A) The expression level of p18 was examined by RT-PCR in different human cancer cell lines. The functionality of p53 is indicated as  and 
in each cell line. Raji cells, which are heterozygous for p53 (Bhatia et al., 1993), are marked as /.
(B) The expression of p18 was also checked at the protein level by focusing on lung cancer cell lines.
(C) The DNA contents for the p18 gene in different cancer cell lines were compared by genomic PCR. Actin was used for a loading control.
The extended PCR cycle generates the p18 gene product from H460 and A549 cell lines but still to amounts less than those from other cell
lines (data not shown).
(D) The expression level of p18 in human leukemia. We obtained total RNAs, isolated from the white blood cells of nine leukemia patients
(five APML cases and four CML cases, kindly provided by T.H. Han), and subjected them to RT-PCR to compare the p18 expression levels.
The expression of p21 was also measured by RT-PCR.
(E) The p18 expression status in the normal and cancerous regions isolated from human liver cancer patients. Total RNAs were isolated from
the normal and cancer regions in the patients’ livers, and RT-PCR was conducted to compare the p18 expression levels. Among the 25
informative samples, the results of eight cases are shown. The low expression of p18 was also observed at a similar frequency in other
samples (data not shown).
Interestingly, the adriamycin-induced phosphoryla- regulated at multiple levels. In this context, it is interest-
ing to note that the ectopic expression of kinase-deadtion and nuclear foci formation of ATM were severely
crippled in the p18/ cells despite the fact that these ATM suppressed the basal expression of p18 (Figure
4E), implying another direction of the controllingmecha-cells should still retain one allele of p18 (Figures 6C
and 6D). This null-like phenotype may result from the nism. Interestingly, the p18 promoter region appears to
harbor a potential binding site for E2F-1(data not shown)possibility that the heterozygous cells may not have
enough p18 to respond to DNA damage. In fact, the p18 that is induced in response to DNA damage via ATM
(Lin et al., 2001). Thus, one can expect the regulatorylevel was more severely reduced in most of the different
p18/ cells, even if the heterozygous cells still retained feedback loop between p18 and ATM. In fact, p18 ex-
pression was shown to be suppressed in the absence ofone allele (Figure 1D). p18 showed rapid response to
genotoxic stresses (Figures 2H, 5A, and 5B), implying ATM (Edgar et al., 2002). This regulatory circuit warrants
further investigation.that it would be controlled at the protein level as well
as at the transcription level. Indeed, the p18 level was We showed that p18-mediated p53 activation is
achieved through a direct interaction with the FAT do-elevated by the inhibition of proteasome activity, and the
DNA damage-dependent phosphorylation of p18 was main of ATM and ATR (Figure 5D). These proteins con-
tain a PI3 kinase-related catalytic domain flanked byobserved (data not shown). Although we have not yet
determined the role of the phosphorylation of p18, it is FAT and C-terminal domains. Although the FAT domain
itself is not expected to have the catalytic activity, it isreminiscent of p53, in which turnover is controlled by
phosphorylation (Prives, 1998). Thus, p18 appears to be thought to play a role in the regulation of the kinase
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PCR analysis, genomic DNA was isolated from the mouse tail andactivity through an intramolecular interaction with the
subjected to a PCR reaction with a combination of three primersC-terminal region (Bosotti et al., 2000). Perhaps thebind-
(p18F-1, GCCGGACTTCCTGCTCAATCAAGGTCCTA; p18R-1, CTAGCing of p18 to the FAT domain may induce a conforma-
GGGTGGATAAGTAGTAGTTTCCTCATG; and LTR, CGTTACTTAAG
tional change of ATM/ATR to the active form, although CTAGCTTGCCACCTAC). For Southern blotting, the isolated geno-
further molecular and biochemical analyses are neces- mic DNA was digested with SacI, separated by gel electrophoresis,
and hybridized with the radioactively labeled 1.5 kb PCR productsary to understand the details behind p18 activation of
of the p18 gene prepared with the specific primer (p18F-2, 5-CATATM. ATM not only participates in cell cycle control
GAGGAAACTACTACTTATCCACCCGCTAG; p18R-2, 5-CCTTCAGvia p53 but also is involved in the DNA repair process
CAGAGTCTGGGTGTCTTCTTTACTG). The expression of p18 was(Abraham, 2001). If p18 is a general activator of ATM/
determined by Western blotting of proteins extracted from 14.5
ATR, it is expected to control DNA repair via these ki- day mouse embryonic fibroblasts with the polyclonal rabbit anti-
nases. In fact, we observed a slight enhancement of p18 antibody.
DNA synthesis when p18 expression was increased by
ectopic transfection into p53- or p21-negative cells (Fig- DNA Construction and Transfection
The cDNAs encoding ATM, ATR, and ATM-KD were kindly providedure 3D). This increase may have resulted from unsched-
by M. Kastan (St. Jude Children’s Hospital) and S. Elledge (Harvarduled DNA synthesis caused by the activated ATM.
Medical School). The cDNAs encoding the FAT and C-terminal do-p53 is a haploinsufficient tumor suppressor (French
mains of ATM were obtained by PCR with their specific primers.
et al., 2001; Ide et al., 2003), which exerts multiple activi- The primers for the FAT and C-terminal domains were designed to
ties in the control of cell proliferation and death. Since generate cDNAs encoding aa 1970–2582 and aa 2919–3054, respec-
tively. The amplified cDNAs were subcloned into pcDNA3.1/V5-His-p18 controls the activity of p53 via ATM, it is expected
TOPO vector for in vitro transcription and translation. To generateto suppress tumorigenesis as well. Here we showed
the antisense p18 construct, we amplified the N-terminal 200 bp ofthat the loss of one p18 allele significantly promoted
the p18 gene containing ATG and cloned it into pcDNA3.1 with thetumorigenesis (Figure 1E), and low p18 expression is
reverse orientation. To make the small interfering p18 construct,
frequently found in different human cancer cell lines the IMG-700 (pSuppressorNeo, Imgenex) vector was used for the
and patient tissues (Figure 7). Interestingly, the reduced construction of 21 bphead-to-headhairpins of humanp18 (GenBank
accession number AB011079). Three 21 bp oligonucleotide se-expression of p18 showed reverse correlation with the
quences specific for human p18 were tested for the suppression offunctionality of p53 in cancer cell lines (Figure 7A). When
p18 expression. For each construct, two complementary oligonucle-we analyzed the functionality of p53 in the cancer cells
otides containing the human p18 sequence were synthesized anddeveloped in the p18/ and p18/ mice, p53 in the
annealed to generate double-stranded DNAs, which were cloned
p18/ cancer cells behaved normally, although p53 did into the SalI and XbaI cloning sites of the pSuppressorNeo plasmid
not respond to DNA damage, implying that p53 itself is according to the manufacturer’s recommendations. The most suc-
cessful sequence found was the 21 bp sequence residing 84 basesfunctional except for its sensitivity to DNA damage due
3 of the ATG, which was site specific to human p18 and lackedto the defect in the regulatory signal from the p18-ATM
significant similarity to other genes. Each of the constructs wasline (data not shown). All of these observations, in con-
introduced to the cells with Geneporter (Gene Therapy Systems)junction with its working mechanism revealed here, fur-
following the manufacturer’s protocol.
ther support the notion that p18 should be a critical
regulator of p53 and can induce tumorigenesis indepen- Flow Cytometry
dently of p53. Comparisons of DNA content demon- The cultivated cells were treated or transfected with the indicated
drug or vector, fixed with 2% paraformaldehyde for 1 hr at 4C,strated that some cancer cell lines might have lost one
washed with ice-cold PBS, and permeabilized with 0.1% Tritonallele of the p18 gene (Figure 7C). In fact, the gene
X-100 and 0.1% BSA containing PBS. After two washes with ice-encoding p18 is located in the chromosome region
cold PBS, the cells were incubated with anti-p18 (1 g/ml) for 1 hr6p24–25, which was previously shown to be the loss-
with agitation at 4C and with the secondary antibody (anti-mouse-
of-heterozygosity (LOH) region in lymphoma (Baumgart- FITC or anti-rabbit FITC; 1 g/ml) for 45 min in the dark. After wash-
ner et al., 2003; Wang et al., 2001). Thus, LOH in this ing with PBS, the cells were stained with PI (50g/ml) for 20 min and
subjected to FACS Calibur (Beckton-Dickinson). For each sample,chromosomal region may be responsible for the lower
15,000 cells were analyzed using the Cell Quest Pro software.expression of p18, although more vigorous studies are
needed to confirm this possibility. Taken together, we
Histological Analyses of Cancers in p18/ Miceconclude that p18 is a haploinsufficient tumor suppres-
After sacrificing the mice, the cancer tissues were isolated and fixedsor working in the signal pathway including ATM/ATR
with 10% formalin, embedded in paraffin, and subjected to H&E
and p53 and propose that it could be a useful marker staining. Immunohistochemical staining for the surfacemarker B220
for various cancers and a target for anticancer drug de- was performed with a paraffin slide to determine B cell metastasis.
After the paraffin was removed with xylene, the slides were incu-velopment.
bated with the B220 antibody in blocking buffer (1:100, 5% BSA,
and 0.1% Tween 20 in PBS) for 2 hr. After washing with PBS, theExperimental Procedures
tissues were incubated with an avidin-conjugated secondary anti-
body and the DAB solution.Genetic Disruption of p18 in Mice
To generate p18-deficient mice, we used the gene trap method
(Zambrowicz et al., 1998). Within the embryonic stem cell library of Luciferase Assay
HCT116 cells were transfected with the vector DNA containing p21-the 129/SvEvBrdmouse, inwhich the gene trap vector was randomly
introduced (OmniBank Library, Lexicon Genetics), we identified the luciferase, in which the luciferase is expressed under p21 promoter
control (kindly provided by H.W. Lee, Sungkyunkwan University,OST377244 clone containing the mutated p18 gene. Using this
clone, C57BL6 mice heterozygous for p18 were generated following Korea) along with the p18 DNA. After lysis, the cell extracts were
incubated with the luciferase substrate for 30 min at RT. Then, a 5the protocol of Lexicon Genetics. The heterozygous mice were in-
terbred to generate the homozygous offspring. To confirm the inser- l aliquot of each samplewas transferred into the luminometer plate,
and the luciferase activity was measured following the manufactur-tion of the gene trap vector and its effect on the expression of p18,




In situ apoptosis detection was conducted with an Apoptag fluores-Twenty-four hours after transfection with the indicated vectors, the
cells were incubated with 1 Ci/ml [3H] thymidine. After washing cein kit (Oncor) following themanufacturer’s manual. Apoptotic cells
were visualized by confocal microscopy.We alsomeasured apopto-twice with ice-cold PBS, the cells were incubated with 10% TCA
for 0.5 hr at 4C to precipitate the nucleic acids. After lysis with 0.1 sis using the splenocytes isolated from thep18wild-type andhetero-
zygous littermates. The cells were incubated with FITC-conjugatedN NaOH, the incorporated radioactive thymidine in the precipitates
was quantified by a liquid scintillation counter. The experiments annexin V or propidum iodide for 5 min. After a brief wash with PBS,
the cells were subjected to FACS analysis with the FL-1H detector.were repeated three times, and the data were averaged.
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